The investing landscape for Mckesson Corporation (NYSE:MCK) is seeing a significant uptick with 88% of company shares currently owned by institutional shareholders. This healthcare giant's stock continues to outperform competitors, despite some losses, and has experienced 25% year-to-date gains, fuelling investor interest. Several share-related actions were taken such as Tocqueville Asset Management and Mitsubishi UFJ Trust & Banking Corp selling part of their shares, while Avantax Advisory Services and Headlands Technologies increased their investments. MCK's stock hit a 52-week high, driven by strong investor confidence, while Citigroup analysts increased the price target to $670.00. Amidst strong revenue growth, Mckesson produced mixed results for fiscal 2024. Despite occasional earnings miss, investors remain bullish, considering it as a top value stock and showing resilience in the market. They state MCK as a safe long-term investment option, with those investing 5 years ago profiting a 340% gain. Mckesson is close to declaring Q4 earnings, and raised full-year guidance, signalling continued optimistic forecasts. In other developments, MCK welcomes Dr. Dunsire as a new board member and pursues a significant incentive for a $108M distribution centre with Port KC.
Mckesson Corporation MCK News Analytics from Mon, 16 Oct 2023 07:00:00 GMT to Sun, 21 Jul 2024 17:19:23 GMT - Rating 8 - Innovation 6 - Information 8 - Rumor -5
